Oculogica’s proprietary, patented technology transforms the way concussion is diagnosed.

Founded by a neurosurgeon and research scientist, Oculogica® has developed the first FDA authorized non-invasive, baseline free, technology to aid in diagnosis of concussion, also known as mild traumatic brain injury (mTBI). Oculogica is also conducting research with world-class medical institutions to bring personalized medicine to concussion diagnosis and treatment, and, ultimately, improve outcomes for the millions of people who annually suffer TBI and concussion.

The Science

Our Team - Oculogica